Form D · Biotechnology

Labcyte Inc

Sunnyvale, CA · CIK 0001167807

Offering snapshot reported Jan 9, 2017 · SEC filing

Reported sold
$5M
Offering amount: $10M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 23, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 9, 2017Initial$4,999,999No comparison1SEC filing
Sep 20, 2013Amendment$5,785,889$501,725vs Jan 7, 201318SEC filing
Jan 7, 2013Initial$5,284,164No comparison16SEC filing
Mar 21, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jul 26, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-278001

Source: Form D, filed Jan 9, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tammy Cameron Executive
Richard Ellson Director, Executive
Mark Fischer Colbrie Director, Executive
Elaine J. Heron Director
Joe Keegan Director
Joseph D. Keegan Director
Jonathan Mac Quitty Director
Andre Marion Director
Sandra Panem Director
Joseph Smith Director
Craig Taylor Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1190 Borregas Ave
Sunnyvale, CA, 94089